Autres langues

16/07 Ingevity Receives BASt Approval For Evotherm P35 Warm-Mix Additive In Germany
16/07 Ingevity’s Evotherm® P35 receives BASt approval in Germany
02/07 Ingevity : announces dates for second quarter 2026 earnings release and webcast
02/07 Ingevity announces dates for second quarter 2026 earnings release and webcast  
25/06 Ingevity Names Ryan Cotterman as Chief Accounting Officer
24/06 Ingevity Corporation Appoints Ryan Cotterman as Vice President, Chief Accounting Officer and Principal Accounting Officer, Effective June 22, 2026
11/06 Dentsply Sirona Appoints John Fortson as Chief Financial Officer
09/06 Ingevity CEO Dave Li and CFO Phillip Platt to speak at 2026 Wells Fargo Industrials & Materials Conference
08/05 Ingevity : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
06/05 Ingevity: Q1 Earnings Snapshot
06/05 Earnings Flash (NGVT) Ingevity Corporation Reports Q1 Revenue $258.0M, vs. FactSet Est of $254.7M
06/05 Earnings Flash (NGVT) Ingevity Corporation Posts Q1 Adjusted EPS $1.15 per Share, vs. FactSet Est of $0.83
06/05 Tranche Update on Ingevity Corporation's Equity Buyback Plan announced on August 2, 2022.
06/05 Ingevity Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
06/05 Ingevity reports first quarter 2026 financial results
06/05 Ingevity Corporation Reaffirms Earnings Guidance for the Full Year 2026
15/04 Ingevity announces sale of Ozark Materials Road Markings business to PPG, strengthening strategic focus
15/04 Ppg acquires pavement markings manufacturer Ozark Materials, LLC
15/04 Ingevity Sells Ozark Materials Road Markings Business to PPG Industries
15/04 Ingevity announces sale of Ozark Materials road markings business to PPG, strengthening strategic focus
08/04 Ingevity announces dates for first quarter 2026 earnings release and webcast
30/03 Ingevity Corporation, Ingevity Holdings SRL, Ingevity UK Ltd Amends And Restates Credit Agreement to Secure USD 750 Million Revolving Credit Facility
30/03 Ingevity Corp - enters second amendment and restatement agreement on March 26, 2026 - SEC filing
20/03 Ingevity : announces temporary extraordinary surcharge on Capa caprolactone products
11/03 $85 Million Verdict Affirmed: Federal Circuit Shuts Down Ingevity's Challenge To Antitrust Verdict
Aucun résultat pour cette recherche